Back to Search
NICHOLAS MITSIADES, M.D., P.HD.
Medical Oncology Physician
NPI: 1508090754IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
47493(TX)
Endocrinology, Diabetes & Metabolism Physician
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
47493(TX)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
47493(TX)A177673(CA)
Education
OTHER
Class of 1995
Research & Publications (20)
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study.
PMID 19051043·Cancer Causes Control·2009
8-other
Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
PMID 19584292·Cancer Res·2009
7-preclinical
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
PMID 19553613·Invest Ophthalmol Vis Sci·2009
7-preclinical
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
PMID 19387079·Invest Ophthalmol Vis Sci·2009
8-other
Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.
PMID 19190079·Endocr Relat Cancer·2009
8-other
Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.
PMID 18310295·Endocr Relat Cancer·2008
4-observational
Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo.
PMID 18593922·Cancer Res·2008
7-preclinical
Molecular pathology of thyroid cancer: diagnostic and clinical implications.
PMID 19041825·Best Pract Res Clin Endocrinol Metab·2008
6-review
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
PMID 17363500·Mol Cancer Ther·2007
8-other
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
PMID 17032924·Blood·2007
7-preclinical
Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.
PMID 17400913·FASEB J·2007
7-preclinical
Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.
PMID 17192291·J Clin Endocrinol Metab·2007
8-other
Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
PMID 17301264·Cancer Epidemiol Biomarkers Prev·2007
8-other
Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
PMID 18424891·Oncology·2007
4-observational
Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
PMID 17546631·J Cell Biochem·2007
6-review
Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease.
PMID 17433850·J Am Acad Dermatol·2007
5-case
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
PMID 17848408·J Clin Endocrinol Metab·2007
8-other
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
PMID 17898295·Invest Ophthalmol Vis Sci·2007
8-other
Proteasome inhibition as a new therapeutic principle in hematological malignancies.
PMID 17073596·Curr Drug Targets·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1504 TAUB LOOP
HOUSTON, TX 77030 - Phone
- (713) 873-8890
Quick Facts
- NPI
- 1508090754
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile